Dahlia Biosciences Company

Dahlia Biosciences is the next generation of multiplexed in situ single-cell RNA analysis tools for research and diagnostic applications.
DAHLIA BIOSCIENCES, INC. provides in situ single-cell RNA analysis tools for research and diagnostic applications. The company was founded in 2017 and is headquartered in San Francisco, California.


Investors

Funding Status: Seed
Headquarters: San Francisco
Founded Date: 2017
Investor Type: N/A
Investment Stage: N/A
Technology: Preventive Diagnostics
Employee Number: 1-10
Number Of Exists: N/A
Industry: Precision Medicine